www.aasraw.com
ALK-Positive Lung Cancer Drug “Ceritinib(LDK378)”
ALK-Positive Lung Cancer Drug “Ceritinib(LDK378)”.............................................................................. 1 CeritinibWasApprovedForUsinginEU................................................................................................2 CeritinibDescription..........................................................................................................................2 HowDoesCeritinibWorkForTreatingNSCLC?.......................................................................................3 HowAboutCeritinibMedicalUses?.....................................................................................................3 HowToStorageCeritinib(LDK378)?......................................................................................................4 WhatIsSideEffectsOfCeritinib?.........................................................................................................4 WhatOtherBenefitsOfCeritinibHaveBeenShownInStudies?................................................................6 CeritinibGetsFirst-LineFDAApprovalforALK-PositiveLungCancer............................................................7 Reference............................................................................................................................... 8
1
AASraw Biochemical Technology Co.,Ltd aas14@aasraw.com